Rein Willemze

Q: What Schools Are Affiliated With Rein Willemze

Rein Willemze is affiliated with the following schools: University of Regensburg, Leiden University

Rein Willemze's AcademicInfluence.com Rankings

Rein Willemze

Medical

#2888

World Rank

#3332

Historical Rank

Dermatology

#61

World Rank

#83

Historical Rank

medical Degrees

Rein Willemze

Philosophy

#8271

World Rank

#11617

Historical Rank

Logic

#5307

World Rank

#6696

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Rein Willemze's Degrees

Doctorate Medicine Leiden University
PhD Dermatology Leiden University

Why Is Rein Willemze Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Rein Willemze's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

WHO-EORTC classification for cutaneous lymphomas. (2005) (3669)
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. (1997) (1347)
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). (2007) (1063)
The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. (2019) (677)
Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment (2000) (595)
Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’ 1 (2004) (552)
Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. (2008) (518)
Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. (2002) (423)
European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. (2008) (412)
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome. (2006) (406)
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. (2011) (367)
Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation (2001) (352)
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017. (2017) (339)
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects (2005) (327)
Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. (1993) (326)
Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients. (2002) (322)
The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. (2003) (321)
Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. (2005) (286)
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model. (2015) (283)
Primary cutaneous CD30‐positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis. A European multicenter study of 47 patients (1993) (281)
Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. (2007) (276)
Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. (2005) (272)
WHO classification of skin tumours (2018) (249)
Primary Cutaneous Large B-Cell Lymphomas of the Legs: A Distinct Type of Cutaneous B-Cell Lymphoma With an Intermediate Prognosis (1996) (246)
Cytotoxic/natural killer cell cutaneous lymphomas (2003) (240)
Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients. (2003) (235)
Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. (2005) (229)
The cell-surface marker MTS24 identifies a novel population of follicular keratinocytes with characteristics of progenitor cells (2006) (219)
An immunodeficiency disease with RAG mutations and granulomas. (2008) (194)
Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome. (2009) (187)
Novel and highly recurrent chromosomal alterations in Sézary syndrome. (2008) (186)
Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group. (2002) (184)
Aberrant Expression of the Tyrosine Kinase Receptor EphA4 and the Transcription Factor Twist in Sézary Syndrome Identified by Gene Expression Analysis (2004) (176)
Primary cutaneous large cell lymphomas of follicular center cell origin. A clinical follow-up study of nineteen patients. (1987) (175)
Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T‐cell or null cell phenotype (1993) (172)
Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases. (2012) (172)
Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. (2007) (168)
Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2010) (168)
Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma Families (2008) (162)
Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases. (2005) (162)
Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). (2008) (158)
Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). (1999) (157)
Indolent CD8-positive Lymphoid Proliferation of the Ear: A Distinct Primary Cutaneous T-cell Lymphoma? (2007) (157)
Effect of smoking and sun on the aging skin. (2003) (148)
Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. (1996) (142)
Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities. (2007) (139)
bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related. (1998) (132)
Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas. (2009) (129)
The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions. (1999) (129)
Expression of Programmed Death-1 in Primary Cutaneous CD4-Positive Small/Medium-Sized Pleomorphic T-Cell Lymphoma, Cutaneous Pseudo-T-Cell Lymphoma, and Other Types of Cutaneous T-Cell Lymphoma (2012) (128)
The CXCR3 Targeting Chemokine CXCL11 Has Potent Antitumor Activity In Vivo Involving Attraction of CD8+ T Lymphocytes But Not Inhibition of Angiogenesis (2005) (127)
MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome. (2011) (125)
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. (2004) (125)
Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma. (2006) (124)
Primary cutaneous T‐cell lymphoma: Clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and cd30‐positive large cell lymphoma (1994) (124)
Characterization of T-cell subpopulations in skin and peripheral blood of patients with cutaneous T-cell lymphomas and benign inflammatory dermatoses. (1983) (121)
Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. (2006) (120)
Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification. (2007) (118)
Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides. (2016) (117)
Subsequent Squamous- and Basal-Cell Carcinomas in Kidney-Transplant Recipients After the First Skin Cancer: Cumulative Incidence and Risk Factors (2010) (110)
TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. (2004) (108)
Diffuse large cell lymphomas of follicular center cell origin presenting in the skin. A clinicopathologic and immunologic study of 16 patients. (1987) (107)
Replacement of animal-derived collagen matrix by human fibroblast-derived dermal matrix for human skin equivalent products. (2009) (104)
ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination (2000) (104)
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer (2006) (104)
Differential expression of programmed death-1 (PD-1) in Sézary syndrome and mycosis fungoides. (2012) (99)
The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment. (2008) (94)
Diagnostic criteria in Sézary's syndrome: a multiparameter study of peripheral blood lymphocytes in 32 patients with erythroderma. (1983) (94)
Classification of cutaneous T‐cell lymphoma: from Alibert to WHO‐EORTC (2006) (93)
Applicability and prognostic value of the new TNM classification system in 135 patients with primary cutaneous anaplastic large cell lymphoma. (2009) (92)
miRNA expression profiling of mycosis fungoides (2011) (89)
The addition of rituximab to anthracycline‐based chemotherapy significantly improves outcome in ‘Western’ patients with intravascular large B‐cell lymphoma (2008) (88)
Cutaneous pseudo‐T‐cell lymphomas. A clinicopathologic study of 20 patients (1992) (88)
Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas. (1997) (85)
Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type. (2009) (82)
Mycosis fungoides-like lesions associated with phenytoin and carbamazepine therapy. (1991) (82)
Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop (2015) (80)
Cucurbitacin I inhibits Stat3 and induces apoptosis in Sézary cells. (2008) (77)
EORTC classification for primary cutaneous lymphomas: the best guide to good clinical management. European Organization for Research and Treatment of Cancer. (1999) (76)
Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients (2013) (76)
Differentiation between lymphadenosis benigna cutis and primary cutaneous follicular center cell lymphomas a comparative clinicopathologic study of 57 patients (1990) (76)
Hematology patterns of migrating European eels and the role of EVEX virus. (2005) (76)
IgM Expression on Paraffin Sections Distinguishes Primary Cutaneous Large B-cell Lymphoma, Leg Type From Primary Cutaneous Follicle Center Lymphoma (2010) (75)
Evaluation of Immunophenotypic and Molecular Biomarkers for Sézary Syndrome Using Standard Operating Procedures: A Multicenter Study of 59 Patients. (2016) (75)
A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides. (2012) (75)
Leiden reconstructed human epidermal model as a tool for the evaluation of the skin corrosion and irritation potential according to the ECVAM guidelines. (2008) (74)
A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma. (2002) (73)
Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease. (1999) (71)
Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: Analysis of 434 cases. (2010) (70)
Incidence of cancer in kidney-transplant recipients: a long-term cohort study in a single center. (2011) (70)
Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (69)
Aberrant DNA methylation in cutaneous malignancies. (2005) (69)
Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B-cell lymphomas and pseudo-B-cell lymphomas: differential diagnostic and pathogenetic aspects. (1992) (68)
Chromosomal aberration patterns differ in subtypes of primary cutaneous B cell lymphomas. (2004) (68)
Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B‐cell lymphoma (2008) (67)
Cutaneous pseudolymphomas: classification and differential diagnosis. (1994) (66)
Primary cutaneous B-cell lymphoma: classification and treatment (2006) (65)
Genomic organization, sequence and transcriptional regulation of the human CXCL 11(1) gene. (1999) (64)
Non-mycosis fungoides cutaneous T-cell lymphomas: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. (2013) (62)
Primary cutaneous lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. (2008) (62)
Chemokine IP-10 expression in cultured human keratinocytes (1998) (62)
Epidermal Interferon-γ Inducible Protein-10 (IP-10) and Monokine Induced by γ-Interferon (Mig) but not IL-8 mRNA Expression is Associated with Epidermotropism in Cutaneous T Cell Lymphomas (1998) (61)
Cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma NOS show distinct chromosomal alterations and differential expression of chemokine receptors and apoptosis regulators. (2010) (61)
Nuclear factor-κB pathway-activating gene aberrancies in primary cutaneous large B-cell lymphoma, leg type. (2014) (59)
Genome‐wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma (2013) (57)
Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. (2004) (57)
VH Gene Analysis of Primary Cutaneous B-Cell Lymphomas: Evidence for Ongoing Somatic Hypermutation and Isotype Switching (1998) (57)
Immunohistochemical studies of lymphadenosis benigna cutis occurring in a tattoo. (1988) (57)
Lymphocytic infiltration of the skin (Jessner): a T‐cell lymphoproliferative disease (1984) (56)
Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study (2017) (56)
A genomic and expression study of AP‐1 in primary cutaneous T‐cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS (2008) (56)
EORTC classification for primary cutaneous lymphomas: a comparison with the R.E.A.L. Classification and the proposed WHO Classification. (2000) (55)
Minor histocompatibility antigens as targets of graft-versus-leukemia reactions (2002) (55)
High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma. (2018) (54)
Normalized ultraviolet (UV) induction of Langerhans cell depletion and neutrophil infiltrates after artificial UVB hardening of patients with polymorphic light eruption (2005) (54)
Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype (2008) (53)
Mycosis fungoides: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. (2013) (53)
Skin diseases among schoolchildren in Ghana, Gabon, and Rwanda (2013) (51)
Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development (2003) (51)
Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID. (2006) (50)
Cutaneous B-cell lymphoproliferative disorders: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. (2013) (49)
Mimics of cutaneous lymphoma: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. (2013) (49)
MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form. (2001) (48)
An in vitro three‐dimensional model of primary human cutaneous squamous cell carcinoma (2009) (48)
Primary cutaneous CD30-positive lymphoproliferative disorders. (2003) (48)
Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma (2006) (48)
Cutaneous T-Cell Lymphoma: Epidemiology, Etiology, and Classification (2003) (47)
Genomic analysis reveals recurrent deletion of JAK‐STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides (2018) (47)
Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor‐stage mycosis fungoides (2012) (47)
Primary cutaneous lymphomas (2000) (47)
Presence of eel viruses in eel species from various geographic regions (2004) (46)
Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group (2017) (46)
Cutaneous pseudo-T-cell lymphomas. (1991) (45)
VH gene analysis of primary cutaneous B-cell lymphomas: evidence for ongoing somatic hypermutation and isotype switching. (1998) (44)
Alopecia Mucinosa Progressing into Mycosis Fungoides: A Long‐Term Follow‐up Study of Two Patients (1988) (43)
Classification of primary cutaneous T‐cell lymphomas (1994) (43)
Diagnostic value of T-cell receptor beta gene rearrangement analysis on peripheral blood lymphocytes of patients with erythroderma. (1991) (43)
More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine (2008) (42)
Classification of primary cutaneous lymphomas. Historical overview and perspectives. (1994) (42)
Are most primary cutaneous B‐cell lymphomas ‘marginal cell lymphomas’? (1995) (41)
Autocrine IL-21 stimulation is involved in the maintenance of constitutive STAT3 activation in Sézary syndrome. (2012) (41)
Deep-sequencing analysis reveals that the miR-199a2/214 cluster within DNM3os represents the vast majority of aberrantly expressed microRNAs in Sézary syndrome. (2012) (41)
Epigenomic Analysis of Sézary Syndrome Defines Patterns of Aberrant DNA Methylation and Identifies Diagnostic Markers. (2016) (41)
Immunohistochemical studies in lymphocytic infiltration of the skin (Jessner) and discoid lupus erythematosus. A comparative study. (1984) (40)
Differentiation between actinic reticuloid and cutaneous T cell lymphoma by T cell receptor gamma gene rearrangement analysis and immunophenotyping. (1998) (40)
HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity (2005) (39)
Differential Expression of Thymus and Activation Regulated Chemokine and Its Receptor CCR4 in Nodal and Cutaneous Anaplastic Large-Cell Lymphomas and Hodgkin's Disease (2002) (39)
Frequency and prognostic significance of clonal T-cell receptor beta-gene rearrangements in the peripheral blood of patients with mycosis fungoides. (1992) (39)
A histologic study of lymph nodes from patients with the sézary syndrome (1986) (39)
Characterization of the dermal infiltrates in Jessner's lymphocytic infiltrate of the skin, polymorphous light eruption and cutaneous lupus erythematosus: differential diagnostic and pathogenetic aspects (1990) (39)
Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (38)
Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2010) (38)
EBV-positive cutaneous B-cell lymphoproliferative disease after imatinib mesylate. (2003) (38)
Lymphomatoid papulosis with a natural killer‐cell phenotype (2001) (37)
Site-specific expression of polycomb-group genes encoding the HPC-HPH/PRC1 complex in clinically defined primary nodal and cutaneous large B-cell lymphomas. (2004) (37)
Peripheral T‐cell lymphomas: a clinicopathological and immunological study of 10 cases (1986) (36)
High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type (2018) (36)
Frequency of central nervous system involvement in primary cutaneous B‐cell lymphoma (2000) (35)
Functional characterization of cancer‐associated fibroblasts of human cutaneous squamous cell carcinoma (2011) (35)
Diagnostic and prognostic significance of clonal T‐cell receptor beta gene rearrangements in lymph nodes of patients with mycosis fungoides (1993) (35)
Methotrexate-associated B-cell Lymphoproliferative Disorders Presenting in the Skin: A Clinicopathologic and Immunophenotypical Study of 10 Cases (2014) (35)
Histiocytic sarcoma (true histiocytic lymphoma): a clinicopathological study of 20 cases (1984) (34)
A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas. (1999) (32)
Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas. (1998) (32)
Identification of selectively expressed genes and antigens in CTCL (2008) (32)
Cutaneous lymphomas with a panniculitic presentation. (2017) (30)
Minor histocompatibility antigen-specific T cells with multiple distinct specificities can be isolated by direct cloning of IFNγ-secreting T cells from patients with relapsed leukemia responding to donor lymphocyte infusion (2005) (30)
CD44 antibody stimulates adhesion of peripheral blood T cells to keratinocytes through the leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway. (1993) (29)
Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients. (2009) (29)
Primary plasma cell leukaemia. A case report and a review of the literature. (1983) (29)
Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study * (2020) (29)
Reticulum cell sarcomas (large cell lymphomas) presenting in the skin. High frequency of true histiocytic lymphoma (1982) (29)
Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis. (2009) (28)
Epstein–Barr virus is present in neoplastic cytotoxic T cells in extranodal, and predominantly in B cells in nodal T non‐Hodgkin lymphomas (2000) (27)
Oral etoposide in the treatment of cutaneous large‐cell lymphomas. A preliminary report of four cases (1992) (26)
Effects of serially passaged fibroblasts on dermal and epidermal morphogenesis in human skin equivalents (2013) (26)
From sporadic atypical nevi to familial melanoma: risk analysis for melanoma in sporadic atypical nevus patients. (2007) (26)
DISTINCTIVE ADHESION PATHWAYS ARE INVOLVED IN EPITHELIOTROPIC PROCESSES AT DIFFERENT SITES (1996) (26)
Leucostasis, an underestimated cause of death in leukaemia (2004) (25)
Bone marrow examination has limited value in the staging of patients with an anaplastic large cell lymphoma first presenting in the skin. Retrospective analysis of 107 patients (2008) (25)
Pentoxifylline inhibits human T-cell adhesion to dermal endothelial cells (1997) (24)
p53 and bcl‐2 expression do not correlate with prognosis in primary cutaneous large T‐cell lymphomas (1997) (23)
The significance of beta-2 microglobulin in clinical medicine. (1985) (23)
Processing of natural and recombinant CXCR3-targeting chemokines and implications for biological activity. (2001) (23)
Reduced IL‐1Ra/IL‐1 ratio in ultraviolet B‐exposed skin of patients with polymorphic light eruption (2009) (23)
Umbilical cord blood contains normal frequencies of cytotoxic T-lymphocyte precursors (ctlp) and helper T-lymphocyte precursors against noninherited maternal antigens and noninherited paternal antigens (1996) (23)
Mycosis fungoides variants—clinicopathologic features, differential diagnosis, and treatment (2018) (23)
MICA gene polymorphism is not associated with an increased risk for skin cancer. (2002) (22)
MicroRNA Profiling of Primary Cutaneous Large B-Cell Lymphomas (2013) (22)
UVB‐induced leucocyte trafficking in the epidermis of photosensitive lupus erythematosus patients: Normal depletion of Langerhans cells (2005) (21)
Classification of cutaneous lymphomas: crosstalk between pathologist and clinician (1998) (20)
Expression of programmed death‐1 in skin biopsies of benign inflammatory vs. lymphomatous erythroderma (2014) (20)
Kidney transplant recipients with cutaneous squamous cell carcinoma have an increased risk of internal malignancy. (2012) (20)
Expression of Fas and Fas ligand in cutaneous B‐cell lymphomas (1999) (20)
Classification of primary cutaneous large cell lymphomas. (1994) (20)
Epidermal transit of replication-arrested, undifferentiated keratinocytes in UV-exposed XPC mice: an alternative to in situ apoptosis. (2005) (20)
Pentoxifylline inhibits T-cell adherence to keratinocytes. (1995) (19)
Similar potential to become activated and proliferate but differential kinetics and profiles of cytokine production of umbilical cord blood T cells and adult blood naive and memory T cells. (2006) (19)
Differential expression of TOX by skin‐infiltrating T cells in Sézary syndrome and erythrodermic dermatitis (2015) (19)
Primary Cutaneous Lymphoma: Recommendations for Clinical Trial Design and Staging Update from the ISCL, USCLC, and EORTC. (2021) (18)
HOXC4, HOXC5, and HOXC6 expression in primary cutaneous lymphoid lesions. High expression of HOXC5 in anaplastic large-cell lymphomas. (1997) (18)
Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: report of the Dutch Cutaneous Lymphoma Group (2018) (18)
Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group. (2017) (18)
Programmed death‐1 expression in cutaneous B‐cell lymphoma (2014) (18)
Quantitative electron microscopy in the early diagnosis of cutaneous T-cell lymphomas. A long-term follow-up study of 77 patients. (1986) (17)
Diagnostic and prognostic significance of CDKN2A/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30‐positive lymphoproliferative disease (2015) (17)
IP-10 mRNA expression in cultured keratinocytes is suppressed by inhibition of protein kinase-C and tyrosine kinase and elevation of cAMP. (1999) (17)
HOXC4, HOXC5, and HOXC6 expression in non-Hodgkin's lymphoma: preferential expression of the HOXC5 gene in primary cutaneous anaplastic T-cell and oro-gastrointestinal tract mucosa-associated B-cell lymphomas. (1997) (17)
distinct disease entities hematodermic neoplasm and cutaneous myelomonocytic leukemia as + CD56 + Gene-expression profiling and array-based CGH classify CD4 (2008) (17)
Relation between expression of adhesion molecules and clinical behavior in cutaneous follicle center cell lymphomas. (1997) (16)
Spectophotometric quantification of cell-cell adherence by an enzyme-linked immuno-cell adhesion assay. (1990) (16)
Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families (2008) (15)
Deregulation of JAK2 signaling underlies primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma (2021) (15)
Classification of primary cutaneous T‐cell lymphomas: Sir (1995) (14)
Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma (2020) (14)
Granulomatous Mycosis Fungoides and Granulomatous Slack Skin (2008) (14)
Primary cutaneous B-cell lymphomas: a practical approach. (2003) (14)
The progenitor cell inhibition assay to measure the anti-leukemic reactivity of T cell clones against acute and chronic myeloid leukemia. (2003) (13)
Mycosis fungoides with extracutaneous localization in the breast (1996) (13)
Human growth factor (huGRO), interleukin-8 (IL-8) and interferon-γ-inducible protein (γ-IP-10) gene expression in cultured normal human keratinocytes (2004) (13)
The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sézary Syndrome: A Multi-institutional and International Pathology Study (2018) (12)
Plaque stage folliculotropic mycosis fungoides: histopathologic features and prognostic factors in a series of 40 patients (2019) (12)
Rapamycin impairs UV induction of mutant‐p53 overexpressing cell clusters without affecting tumor onset (2012) (12)
The significance of Leu 8 negative T cells in lymphoid skin infiltrates: malignant transformation, selective homing or T‐cell activation? (1990) (12)
Folliculotropic mycosis fungoides presenting with a solitary lesion: Clinicopathological features and long‐term follow‐up data in a series of 9 cases (2018) (11)
Primary cutaneous peripheral T‐cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico‐pathological and prognostic features (2020) (11)
[Diagnosis and classification of cutaneous pseudolymphoma. Historical review and perspectives]. (1993) (11)
Recent advances in primary cutaneous B-cell lymphomas (2014) (11)
Regulatory activity of neoplastic T cells in Sezary syndrome on in vitro immunoglobulin production. (1984) (11)
No TP63 rearrangements in a selected group of primary cutaneous CD30+ lymphoproliferative disorders with aggressive clinical course. (2016) (11)
CD30-Negative Cutaneous T-Cell Lymphomas Other than Mycosis Fungoides. (2014) (10)
Increased risk of second cancers in managing Hodgkin's disease: the 20-year Leiden experience (1992) (10)
Intercellular distribution of HLA‐DR and T6 antigens in the epidermis of various dcrmatoses (1985) (10)
9325 Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: analysis of 434 cases (2009) (10)
Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas (2022) (10)
Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas. (2001) (10)
Rationale of a new classification for the group of primary cutaneous lymphomas. (2000) (10)
Dietary Immunosuppressants Do Not Enhance UV-Induced Skin Carcinogenesis, and Reveal Discordance between p53-Mutant Early Clones and Carcinomas (2012) (9)
Human growth factor (huGRO), interleukin-8 (IL-8) and interferon-gamma-inducible protein (gamma-IP-10) gene expression in cultured normal human keratinocytes. (1994) (9)
Thirty years of progress in cutaneous lymphoma research. (2012) (9)
Quality of life in patients with Mycosis Fungoides and Sézary Syndrome: a systematic review of the literature (2021) (9)
Whole‐genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm (2019) (9)
Thrombocytopenic purpura, coeliac disease and IgA deficiency. (1986) (9)
Differential Diagnosis of Cutaneous Large Cell Lymphomas Using Monoclonal Antibodies Reactive in Paraffin‐Embedded Skin Biopsy Specimens (1991) (9)
Increased adherence to keratinocytes of peripheral blood mononuclear leucocytes of a patient with drug‐induced erythema multiforme (1993) (9)
TOX expression in cutaneous B-cell lymphomas (2016) (9)
Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study * (2021) (8)
Acquired N-linked glycosylation motifs in B-cell receptors of primary cutaneous B-cell lymphoma and the normal B-cell repertoire. (2019) (8)
Clinical, histopathological and prognostic features of primary cutaneous acral CD8+ T‐cell lymphoma and other dermal CD8+ cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop * (2022) (8)
Analysis of non-neoplastic cells in cutaneous B-cell lymphomas. (1984) (8)
Pitfalls in diagnosing primary cutaneous aggressive epidermotropic CD8+ T‐cell lymphoma (2018) (7)
Lymphomatoid papulosis and Hodgkin's disease: Are they related? (2004) (7)
Lymphadenosis benigna cutis versus primary cutaneous B-cell lymphomas of follicular center cell origin. (1989) (7)
Prognostic factors in cutaneous T-cell lymphoma (2009) (7)
Array‐based CGH of primary cutaneous CD8+ aggressive EPIDERMO‐tropic cytotoxic T‐cell lymphoma (2018) (7)
Azathioprine-induced microsatellite instability is not observed in skin carcinomas of organ transplant recipients. (2009) (7)
NPM-ALK expression as a diagnostic marker in cutaneous CD30 positive T-cell lymphoproliferative disorders (1998) (6)
Monoclonal antibodies in the histopathological diagnosis of non-Hodgkin lymphomas. (1985) (6)
Increased Expression of PLS3 Correlates with Better Outcome in Sézary Syndrome. (2017) (6)
Fine-mapping chromosomal loss at 9 p 21 : correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma , leg type Journal of Investigative Dermatology , in press (2009) (6)
Umbilical cord blood-naive T cells but not adult blood-naive T cells require HLA class II on antigen-presenting cells for allo-immune activation. (2004) (6)
Tumor‐stage mycosis fungoides of the vulva successfully treated with local low‐dose radiotherapy (2015) (5)
Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous disease. (2020) (5)
Solitary plasmocytoma of the vagina. (1981) (5)
Classification for Primary Cutaneous Lymphomas : A Proposal From the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer (1997) (5)
Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator (2022) (5)
Ethnicity in mycosis fungoides: white patients present at an older age and with more advanced disease (2019) (5)
The clinical spectrum of mycosis fungoides in Tanzania, East Africa (2017) (5)
No Acceleration of UV-Induced Skin Carcinogenesis from Evenly Spread Dietary Intake of Cyclosporine in Contrast to Oral Bolus Dosages (2013) (4)
Generalized Molluscum Contagiosum Successfully Treated with Interferon-Alpha in a Patient with Folliculotropic Mycosis Fungoides (2019) (4)
Primary Cutaneous CD30 (KI-1) Positive Large Cell Lymphomas: Definition and Differential Diagnostic Aspects (1994) (4)
Corresponding anaplastic lymphoma kinase–tropomyosin 3 (ALK-TPM3) fusion in a patient with a primary cutaneous anaplastic large-cell lymphoma and a Spitz nevus (2019) (4)
Clear cell acanthoma on the dorsum of the hand (2016) (4)
Cutaneous large cell lymphomas of T cell origin: diagnosis, classification and prognostic parameters. (1989) (4)
Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma (2021) (4)
Pentoxifylline (PTX) inhibits interferon-γ (IFN-γ) induced IP-10 mRNA expression in cultured human keratinocytes (KC) (1994) (3)
p16 immunostaining in keratinocytic neoplasia in organ transplant recipients: Bowen's disease shows a characteristic pattern (2017) (3)
High rates of molecular response and low incidence of mutations in patients treated with newly diagnosed chronic myeloid leukemia (CML) treated with a dose-escalated combination of imatinib and cytarabin. (2004) (3)
Effect of calcitriol on growth, differentiation, chemokine mRNA expression of cultured keratinocytes and on keratinocyte-T cell binding. (1994) (3)
Absence of TH 2 Cytokine Messenger RNA Expression in CD 30-Negative Primary Cutaneous Large T-Cell Lymphomas (2001) (3)
Commentary on "Cutaneous Manifestations of Lymphoma: A Clinical Guide Based on the WHO Classification" (2001) (3)
Expression of cell adhesion molecules in lymphoid malignancies. (1990) (2)
Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study) (2020) (2)
Primary cutaneous lymphoma: the 2018 update of the WHO-EORTC classification. (2022) (2)
Changing Concepts on Cutaneous Pseudo-B Cell Lymphomas and their Relationship to Cutaneous B Cell Lymphomas (1994) (2)
Induction of ICAM-1 expression by epidermal keratinocytes via a paracrine pathway possibly involving dermal dendritic cells (2004) (2)
A rare case of cutaneous Epstein-Barr virus–negative intravascular cytotoxic T-cell lymphoma (2019) (2)
Lymphomatoid papulosis. (1985) (2)
516 Global collaboration for establishment of a prognostic index in mycosis fungoides & Sezary Syndrome (2018) (2)
Serum and cutaneous transcriptional expression levels of IL31 are minimal in cutaneous T cell lymphoma variants (2021) (2)
Lymph node histopathology in mycosis fungoides and Sézary's syndrome. (1989) (2)
Hyperthyroidism following mantlefield irradiation for Hodgkin's disease. (1982) (2)
Spectophotometric quantification of T-lymphocytes adherence to keratinocytes by enzyme linked immuno cell adhesion assay (ELICAA) (1989) (1)
Limited effect of chemotherapy in cutaneous lymphoma. (2015) (1)
Tumor progression in cutaneous T-cell lymphoma (1998) (1)
Cutaneous T-Cell Lymphomas in Childhood and Adolescence (2019) (1)
Progression of mycosis fungoides is associated with expression of granzyme B and TIA-1 in neoplastic cells (1998) (1)
[CD56-positive 'natural killer'/T-cell lymphoma]. (2001) (1)
Clonality in sarcoidosis , granuloma annulare , and granulomatous mycosis fungoides (1)
p53-specific serum antibodies are not associated with a history of skin carcinoma in renal transplant recipients and immunocompetent individuals. (2005) (1)
Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families (2008) (1)
Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients (2013) (1)
Guidelines entitled : “ EORTC consensus recommendations for the treatment of mycosis fungoides / Sézary syndrome ” developed by the Guideline (2005) (1)
The risk of cancer is not increased in patients with multiple kidney transplantations. (2012) (1)
Abstract LB-012: Autonomous, antigen-independent B-cell receptor signalling as a novel pathogenetic mechanism in non-GCB DLBCL (2016) (1)
Distribution of T-cell subpopulations in the peripheral blood of patients with erythrodermic psoriasis (1984) (1)
Differential expression of IFN-γ induced CXC chemokines IP-10 and MIG in inflammatory skin diseases (1998) (1)
Prognostic factors in mycosis fungoides: the PROCLIPI study (2019) (1)
Antigen-Independent, Autonomous B-Cell Receptor Signaling As a Dominant Candidate Oncogenic Mechanism in ABC DLBCL (2016) (1)
Mass Cytometric Analysis of Early-Stage Mycosis Fungoides (2022) (1)
Case 49. Adult T-cell leukemia/lymphoma (2021) (0)
The significance of leu 8 negative t cell in the skin of mycosis fungoides malignant transformation or t cell activation (1989) (0)
CUTANEOUS PSEUDO-T-CELL LYMPHOMA AND OTHER TYPES OF CUTANEOUS T-CELL LYMPHOMA (2016) (0)
Potent B Cell Leukemia-Reactive T Cells Present in Naive Donor T Cell Populations Can Be Isolated under GMP Conditions Using a Universal Stimulation and Isolation Procedure. (2006) (0)
PF509 MOLECULAR ANALYSIS OF PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA LEG TYPE AT DIAGNOSIS AND RELAPSE – IMPLICATIONS FOR TARGETED THERAPIES (2019) (0)
Rein Willemze analysis of 100 cases Prognostic factors in transformed mycosis fungoides : a retrospective (2012) (0)
Effects of serially passaged fibroblasts on dermal and epidermal morphogenesis in human skin equivalents (2013) (0)
Genomic analysis reveals recurrent deletion of HNRNPK and SOCS1 in mycosis fungoides (2018) (0)
Indolent Cutaneous T-Cell Lymphomas (2021) (0)
Treatment of early-stage mycosis fungoides: Results from the PROCLIPI study (2018) (0)
Tumor clone frequency calculation using high throughput sequencing of the T-cell receptor β gene in folliculotropic mycosis fungoides patients. (2022) (0)
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion (2022) (0)
Classification and recommended treatment options for folliculotropic mycosis fungoides (2018) (0)
microRNA deep sequencing in Sezary Syndrome (2013) (0)
IL-17 Genetics of the FAMMM Syndrome (2003) (0)
Faculty Opinions recommendation of Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. (2006) (0)
5 Reduced IL 1 Ra / IL 1 ratio in UVB-exposed skin of patients with polymorphic light eruption (2008) (0)
Quality of life in patients with mycosis fungoides and Sézary syndrome: a review of the literature (2021) (0)
Treatment of early-phase mycosis fungoides: results from the Prospective Cutaneous Lymphoma International (PROCLIPI) study (2019) (0)
Media WatchCutaneous lymphomasCutaneous Lymphomas, Günter Burg, Werner Kempf (Eds.), Taylor & Francis (2005), £115 (US$206·00, €169·63), pp 556, ISBN: 0 82 4729978 (2005) (0)
ADHESION MOLECULES INVOLVED IN THE EXTRAVASATION OF LYMPHOCYTES IN LYMPHOID ORGANS AND CHRONICALLY INFLAMED TISSUES (1994) (0)
Erratum: Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families (European Journal of Human Genetics (2008) 10.38/ejhg.2008.72) (2008) (0)
Prognostic value of histopathologic features in folliculotropic mycosis fungoides presenting with plaques (2019) (0)
Diagnostic and Prognostic Significance of Clonal T-Cell Receptor Gene Rearrangements in the Peripheral Blood of Patients with Cutaneous T-Cell Lymphoma (1994) (0)
Lymph node imaging in patch/plaque mycosis fungoides; enlarged LN are infrequent but lymphomatous nodal involvement may occur and upstage patients to advanced disease (2018) (0)
environment switched immunoglobulins and develop in a T helper type 2 inflammatory The majority of cutaneous marginal zone B cell lymphomas express class (2013) (0)
large-cell lymphoma disorders: lymphomatoid papulosis and primary cutaneous anaplastic treatment of primary cutaneous CD30-positive lymphoproliferative EORTC, ISCL, and USCLC consensus recommendations for the (2012) (0)
Quality of Life in Cutaneous T-cell Lymphoma Patients Receiving Mogamulizumab: Important Factors to Consider (2022) (0)
Tumors of Skin-Homing Lymphocytes (2004) (0)
Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease Monitoring (2022) (0)
Identification of IP-9, a novel CXC-chemokine expressed by keratinocytes (1998) (0)
Itch as a quality of life indicator in patients with cutaneous T cell lymphoma (2022) (0)
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion. (2023) (0)
First Line Treatment of Aggressive Cutaneous NK/T Cell Lymphomas Based on High Dose Cytarabine and Stem Cell Transplantation Does Not Lead to Durable Remissions. (2006) (0)
Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: A retrospective analysis of treatment outcomes and selection for high or low dose schedule (2022) (0)
recommendations for the management of cutaneous B-cell lymphomas International Society for Cutaneous Lymphoma consensus European Organization for Research and Treatment of Cancer and (2008) (0)
Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel (2023) (0)
Frequency of associated haematologic malignancies in lymphomatoid papulosis: A preliminary report of 505 patients from the Dutch Cutaneous Lymphoma Group (2018) (0)
European Organization of Research and Treatment of Cancer (EORTC) Lymphomas (ISCL) and the cutaneous lymphoma task force of the Sézary syndrome: a proposal of the International Society for Cutaneous Revisions to the staging and classification of mycosis fungoides and (2009) (0)
Replicative senescent fibroblasts alter the collagen metabolism in fibroblast-derived-matrix skin equivalents (2011) (0)
Molecular analysis of primary cutaneous diffuse large B-cell lymphoma, leg type at diagnosis and relapse (2019) (0)
Incidence of mycosis fungoides and Sézary syndrome in the Netherlands in the last two decades (2021) (0)
Chapter 24 – Cutaneous B-Cell Lymphoma (2006) (0)
Array-based comparative genomic hybridization analysis of aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma (AECD8+L), extranodal NK/T nasal type lymphoma (ENK/T-NT) and blastic plasmocytoid dendritic cell neoplasia (BPDCN) (2010) (0)
Indirect presentation HLA class II restricted minor histocompatibility antigens is a characteristic of HLA-DM resistant antigens (2010) (0)
Contents, Vol. 189, Supplement 2, 1994 (1994) (0)
The B-Cell Receptor of Primary Cutaneous Follicle Center Lymphoma : Implications for Pathogenesis (2016) (0)
Reply (1986) (0)
Primary Cutaneous Follicle Center Lymphomas (PCFCL) Express Heavily Mutated B-Cell Receptors with Acquired N-Glycosylation Motifs and Lack Ongoing Somatic Hypermutation (2018) (0)
Reply to Correspondence to “Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator” (2022) (0)
Validation of molecular markers of skin sensitization by gene silencing in 3D reconstructed skin models (2009) (0)
Clues for disease progression at time of diagnosis in patients with primary cutaneous follicle center lymphoma (2021) (0)
[A spontaneously resolving T-cell lymphoma]. (2011) (0)
5 Reduced IL1Ra/IL1 ratio in UVB-exposed skin of patients with polymorphic light eruption (2008) (0)
S076 EORTC classification of primary cutaneous lymphoma (1997) (0)
Adult T-celleukemie/lymfoom (ATLL) (2010) (0)
PROGRAMMED DEATH-1 EXPRESSION IN CUTANEOUS B-CELL LYMPHOMA 6 (2016) (0)
Resistance of Quiescent Cells to T Cell Attack Determines Both the Efficacy and Specificity of Adoptive T Cell Therapy. (2006) (0)
Time-to-next-treatment and time-to-next-systemic treatment in patients included in the PROCLIPI registry (2021) (0)
Normalized UV induction of Langerhans cell depletion and neutrophil infiltrates after artificial UVB hardening of patients with polymorphic light eruption (2008) (0)
Leukocyte, leukaemia and drugs (1984) (0)
[A difficult way to diagnosis sarcoidosis]. (2006) (0)
CXCR3 targeted chemokine therapy in cutaneous T-cell lymphoma (2000) (0)
Depletion of In-Vivo Activated Regulatory T Cells Followed by Synchronized Specific In-Vitro Activation Allows the Rapid Isolation of Leukemia-Reactive T Cells for Immunotherapy. (2004) (0)
Evaluation of quantitative electron microscopic methods in the early diagnosis of cutaneous T-cell lymphomas (1986) (0)
Case 1: Carcinoma or Large-Cell Lymphoma? Immunohistochemical Approach of Undifferentiated Tumors in the Skin (1987) (0)
Classification of Cutaneous Lymphomas-Reply (1996) (0)
Upregulation of the polycomb group protein EZH2 in proliferating, cultured mantle cell lymphoma. (2000) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Rein Willemze?

Rein Willemze is affiliated with the following schools:

Rein Willemze's Academic­Influence.com Rankings

Rein Willemze's Degrees

Why Is Rein Willemze Influential?

Rein Willemze's Published Works

Published Works

What Schools Are Affiliated With Rein Willemze?

Rein Willemze's AcademicInfluence.com Rankings